We are looking for technical, scientific presentations from speakers who can share data and lessons learned from their oligonucleotide, peptide, mRNA, genome editing and drug delivery programs. Case studies of preclinical, clinical and CMC projects are highly desired. 

We are looking for presentations in the following topic areas:

• Chemistries Enabling Oligo Conjugates
• Evolution and Innovation in Peptide Manufacturing/CMC
• Design to Development: Case Studies of Peptide Therapeutic Translation to Clinic
• Hybrid Modalities: Peptide–drug Conjugates, Peptide–oligo Conjugates, AOCs
• Oligos for CNS Diseases
• Oligo Discovery & Design, Chemistry, and Preclinical Updates
• Structural (SAR) Basis of RNA to Expand Therapeutic Potential, Delivery & Chemistry
• Analytical and Regulatory CMC Strategies for Oligonucleotides
• Reshaping TIDES Manufacturing with a Focus on Sustainability
• mRNA Analytical and Characterization Strategies
• mRNA Therapeutic and Vaccine Program Updates (Non-Infectious Disease)
• Blood-Brain Barrier Crossing Technology with Oligonucleotides
• Liquid Phase Peptide Synthesis
• GLP-1 Peptide Therapeutics: Preclinical & Clinical Updates
• Genome Editing Preclinical/Clinical Updates, Delivery or CMC
• Targeted Drug Delivery for Oligos, Peptides, mRNA, Genome Editing
• Oligo/Peptide CMC Case Studies: Efficiencies, Scale-up, New Modalities, Cost Savings
• Oligo/Peptide/mRNA/Genome Editing Discovery or Clinical: Case Studies
• Targeted Peptide Radiopharmaceuticals

Poster Hall Hours

Tuesday, May 10, 2016
3:00 pm - 6:30 pm

Wednesday, May 11, 2016
10:00 am - 6:30 pm

Thursday, May 12, 2016
10:30 am - 2:00 pm

Presentations should be free of commercial bias as well as any references to commercial products and services. All selected faculty are required to disclose the existence of any significant financial interest. Financial interest may affect the consideration of your presentation/proposal application.

View our Privacy Policy

PLEASE FILL OUT FORM BELOW IF INTERESTED IN SPEAKING: